NCT00958750

Efficacy and Safety Study to Compare Two Minoxidil Formulations on Women With Androgenetic Alopecia

Investigator-initiated Single Blind, Two-armed, Randomized Phase 3 Clinical Trial to Compare Efficacy of 5% Minoxidil Topical Foam (5% Mtf) Once Daily Versus 2% Minoxidil Topical Solution (2% Mts) Twice Daily in Application on Females With Slightly to Moderate Androgenetic Alopecia Concerning Hair Volume

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 113 (actual)
• Sponsor: Charite University, Berlin, Germany · Academic / Other
• Sex: Female
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine in women the risk/benefit profile and non-inferiority of a topical 5% Minoxidil foam formulation applied once daily for the treatment of androgenetic alopecia in comparison to 2% MTS used twice daily, using objective and subjective efficacy measures and safety assessments for a study period of 24 weeks.

Conditions

• Androgenetic Alopecia
• Female Pattern Hair Loss

Interventions

Type	Name	Description
DRUG	minoxidil	the investigators compared two different formulations and concentrations of minoxidil in this study

Timeline

• Start date: 2008-06-01
• Primary completion: 2009-02-01
• Completion: 2009-06-01
• First posted: 2009-08-13
• Last updated: 2011-11-18

Locations

1 site across 1 country: Germany